237 related articles for article (PubMed ID: 28009606)
21. KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease.
Viola D; Giani C; Mazzeo S; Ugolini C; Ciampi R; Molinaro E; Agate L; Borrelli N; Chella A; Fontanini G; Basolo F; Elisei R
J Clin Endocrinol Metab; 2017 Sep; 102(9):3091-3096. PubMed ID: 28911147
[TBL] [Abstract][Full Text] [Related]
22. Cribriform-morular variant of papillary thyroid carcinoma in an 8-year-old girl: a case report with immunohistochemical and molecular testing.
Rossi ED; Revelli L; Martini M; Taddei A; Pintus C; Panunzi C; Fadda G
Int J Surg Pathol; 2012 Dec; 20(6):629-32. PubMed ID: 22494995
[TBL] [Abstract][Full Text] [Related]
23. Hobnail variant of papillary thyroid carcinoma: A case with an unusual presentation.
Lilo MT; Bishop JA; Ali SZ
Diagn Cytopathol; 2017 Aug; 45(8):754-756. PubMed ID: 28419762
[TBL] [Abstract][Full Text] [Related]
24. Clinical-Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma.
Poma AM; Macerola E; Proietti A; Vignali P; Sparavelli R; Torregrossa L; Matrone A; Basolo A; Elisei R; Santini F; Ugolini C
Front Endocrinol (Lausanne); 2022; 13():842424. PubMed ID: 35311230
[TBL] [Abstract][Full Text] [Related]
25. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D
APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533
[TBL] [Abstract][Full Text] [Related]
26. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
27. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case report and literature review.
Oishi N; Kondo T; Nakazawa T; Mochizuki K; Kasai K; Inoue T; Yamamoto T; Watanabe H; Hatsushika K; Masuyama K; Katoh R
Pathol Res Pract; 2014 Dec; 210(12):1142-5. PubMed ID: 24893893
[TBL] [Abstract][Full Text] [Related]
28. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
29. Columnar cell variant of papillary thyroid carcinoma: a study of 10 cases with emphasis on CDX2 expression.
Sujoy V; Pinto A; Nosé V
Thyroid; 2013 Jun; 23(6):714-9. PubMed ID: 23488912
[TBL] [Abstract][Full Text] [Related]
30. Papillary thyroid carcinoma expressing CD20.
Sasaki Y; Seto M; Miyoshi H; Okada S; Yokoyama S; Ohshima A; Ohshima K
Pathol Int; 2017 Jul; 67(7):350-354. PubMed ID: 28618063
[TBL] [Abstract][Full Text] [Related]
31. Hobnail Variant of Papillary Thyroid Carcinoma: a Literature Review.
Ambrosi F; Righi A; Ricci C; Erickson LA; Lloyd RV; Asioli S
Endocr Pathol; 2017 Dec; 28(4):293-301. PubMed ID: 29019044
[TBL] [Abstract][Full Text] [Related]
32. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
Sohn SY; Park WY; Shin HT; Bae JS; Ki CS; Oh YL; Kim SW; Chung JH
Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368
[TBL] [Abstract][Full Text] [Related]
33. Single Point Mutations in Pediatric Differentiated Thyroid Cancer.
Alzahrani AS; Murugan AK; Qasem E; Alswailem M; Al-Hindi H; Shi Y
Thyroid; 2017 Feb; 27(2):189-196. PubMed ID: 27824297
[TBL] [Abstract][Full Text] [Related]
34. Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma.
Choi YW; Kim YH; Lee J; Soh EY; Park TJ; Kim JH
Hum Pathol; 2015 Oct; 46(10):1557-65. PubMed ID: 26297257
[TBL] [Abstract][Full Text] [Related]
35. PANCREAS METASTASES FROM PAPILLARY THYROID CARCINOMA: A REVIEW OF THE LITERATURE.
Davidson M; Olsen RJ; Ewton AA; Robbins RJ
Endocr Pract; 2017 Dec; 23(12):1425-1429. PubMed ID: 29144798
[TBL] [Abstract][Full Text] [Related]
36. Identification of Unique, Heterozygous Germline Mutation, STK11 (p.F354L), in a Child with an Encapsulated Follicular Variant of Papillary Thyroid Carcinoma within Six Months of Completing Treatment for Neuroblastoma.
Buryk MA; Picarsic JL; Creary SE; Shaw PH; Simons JP; Deutsch M; Monaco SE; Nikiforov YE; Witchel SF
Pediatr Dev Pathol; 2015; 18(4):318-23. PubMed ID: 25751324
[TBL] [Abstract][Full Text] [Related]
37. Iodine regulates G2/M progression induced by CCL21/CCR7 interaction in primary cultures of papillary thyroid cancer cells with RET/PTC expression.
Zhang YY; Liu ZB; Ye XG; Ren WM
Mol Med Rep; 2016 Oct; 14(4):3941-6. PubMed ID: 27574129
[TBL] [Abstract][Full Text] [Related]
38. Cribriform-morular variant of papillary thyroid carcinoma: a study of 3 cases featuring the PIK3CA mutation.
Kwon MJ; Rho YS; Jeong JC; Shin HS; Lee JS; Cho SJ; Nam ES
Hum Pathol; 2015 Aug; 46(8):1180-8. PubMed ID: 26054797
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathological factors in risk prediction of lymph node metastasis in papillary thyroid carcinoma].
Yue C; Zhang Y; Xing L; Zhao Y; Chen J; Jin Y; Liu H
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3637-41. PubMed ID: 25622954
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic metastasis arising from a BRAF(V600E)-positive papillary thyroid cancer: the role of endoscopic ultrasound-guided biopsy and response to sorafenib therapy.
Alzahrani AS; AlQaraawi A; Al Sohaibani F; Almanea H; Abalkhail H
Thyroid; 2012 May; 22(5):536-41. PubMed ID: 22435913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
